Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs
- 21 February 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (10), 1109-1111
- https://doi.org/10.1093/eurheartj/ehaa077
Abstract
This editorial refers to ‘Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study’, by H.-K. Huang et al., doi:10.1093/eurheartj/ehz952.Keywords
This publication has 15 references indexed in Scilit:
- Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulantsOpen Heart, 2018
- Dietary reference values for vitamin KEFSA Journal, 2017
- Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in DenmarkScientific Reports, 2016
- Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2015
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)Thrombosis and Haemostasis, 2013
- Osteoporosis: now and the futureThe Lancet, 2011
- Increased bone formation in osteocalcin-deficient miceNature, 1996
- The quantitative determination of vitamin K. I.Biochemical Journal, 1936
- The antihaemorrhagic vitamin of the chickBiochemical Journal, 1935